MDCX
Medicus Pharma Ltd. Common Stock (MDCX)
Healthcare • NASDAQ • $0.34+6.69%
- Symbol
- MDCX
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Price
- $0.34
- Daily Change
- +6.69%
- Market Cap
- $18.48M
- Trailing P/E
- N/A
- Forward P/E
- -0.83
- 52W High
- $8.94
- 52W Low
- $0.25
- Analyst Target
- $6.50
- Dividend Yield
- N/A
- Beta
- -0.91
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Company websiteResearch MDCX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.